Skip to main content

ADVERTISEMENT

Onil Gleeton, MD

Original Contribution
08/01/2008
Drug-eluting stents (DES) have revolutionized modern interventional cardiology by providing distinct advantages over bare-metal stents (BMS) in reducing the risk of in-stent restenosis. Several randomized clinical trials have consistently...
Drug-eluting stents (DES) have revolutionized modern interventional cardiology by providing distinct advantages over bare-metal stents (BMS) in reducing the risk of in-stent restenosis. Several randomized clinical trials have consistently...
Drug-eluting stents (DES) have...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
08/01/2008
The transradial artery approach (TRA) for coronary interventions is now well accepted as a safe and cost-effective alternative to the traditional transfemoral approach (TFA).1,2 In our center, more than 90% of coronary interventions are...
The transradial artery approach (TRA) for coronary interventions is now well accepted as a safe and cost-effective alternative to the traditional transfemoral approach (TFA).1,2 In our center, more than 90% of coronary interventions are...
The transradial artery approach...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
11/04/2008
To Reduce Door-to-Balloon Time in ST-Elevation Myocardial Infarction Patients ABSTRACT: Background. In ST-segment elevation acute myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (PCI), all efforts...
To Reduce Door-to-Balloon Time in ST-Elevation Myocardial Infarction Patients ABSTRACT: Background. In ST-segment elevation acute myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (PCI), all efforts...
To Reduce Door-to-Balloon Time...
11/04/2008
Journal of Invasive Cardiology
Original Contribution
08/01/2008
Drug-eluting stents (DES) have revolutionized modern interventional cardiology by providing distinct advantages over bare-metal stents (BMS) in reducing the risk of in-stent restenosis. Several randomized clinical trials have consistently...
Drug-eluting stents (DES) have revolutionized modern interventional cardiology by providing distinct advantages over bare-metal stents (BMS) in reducing the risk of in-stent restenosis. Several randomized clinical trials have consistently...
Drug-eluting stents (DES) have...
08/01/2008
Journal of Invasive Cardiology